about
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesTumor necrosis factor-α signaling in macrophages.Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomographyT cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritisEarly changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritisEffects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis.TNFalpha blockade in human diseases: mechanisms and future directions.Mechanisms of bone loss in rheumatoid arthritis.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Etanercept Promotes Bone Formation via Suppression of Dickkopf-1 Expression in Rats with Collagen-Induced Arthritis.Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis.Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues.Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis.Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats.
P2860
Q28570898-146B5A89-2D14-4402-8CE3-4757913DEA5BQ34734335-E5091C89-64E5-44E6-B095-F109338CF480Q35086184-2F04A32B-D2B1-45E0-BB50-07FB9676B7A3Q35554105-4FA147DD-42D0-4A4D-BC3C-CD592B0C58EAQ35620364-3DFB630C-7D61-41B7-8758-D6503D683F52Q36245404-4E12DF9A-41E9-4E56-8BA8-3452602EFC28Q36536886-E1C69DA9-0413-4483-8DA9-E50A10E1AE28Q36618009-BDDA29C3-9EC5-4C99-962A-AE7FE3BCC1B5Q36860987-EEBAE931-32B1-45C1-A15B-25EC7B65E07DQ37140765-FE125277-9666-4B4A-A3BE-E117C6E38226Q37524529-773141F7-9D67-4F7B-8394-C40BCDD19952Q37812618-2352277D-0F2D-4F2E-B4F2-977D365A4FABQ40643961-E065A90F-6A99-4BA4-A6A1-C4C51B3F613CQ54188388-4D10EE3B-93BD-4FC7-8382-ACCB40507DEA
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathogenesis of bone lesions in rheumatoid arthritis.
@ast
Pathogenesis of bone lesions in rheumatoid arthritis.
@en
Pathogenesis of bone lesions in rheumatoid arthritis.
@nl
type
label
Pathogenesis of bone lesions in rheumatoid arthritis.
@ast
Pathogenesis of bone lesions in rheumatoid arthritis.
@en
Pathogenesis of bone lesions in rheumatoid arthritis.
@nl
prefLabel
Pathogenesis of bone lesions in rheumatoid arthritis.
@ast
Pathogenesis of bone lesions in rheumatoid arthritis.
@en
Pathogenesis of bone lesions in rheumatoid arthritis.
@nl
P2860
P1476
Pathogenesis of bone lesions in rheumatoid arthritis.
@en
P2093
Ellen M Gravallese
Steven R Goldring
P2860
P2888
P304
P356
10.1007/S11926-002-0069-Y
P577
2002-06-01T00:00:00Z
P6179
1019883328